Search Results - Richard Rubenstein
- Showing 1 - 2 results of 2
-
1
Linked alterations in structure and autoimmunity biomarkers in remote mild-to-moderate TBI: A multi-modal brain imaging study by Abigail B. Waters, Samantha H. Penhale, Shoumi Sarkar, Somnath Datta, Damon G. Lamb, Claudia Robertson, Richard Rubenstein, Amy K. Wagner, Firas Kobeissy, Kevin Wang, John B. Williamson
Published 2025-01-01Background: There is significant heterogeneity in the recovery course from mild-to-moderate traumatic brain injury (mmTBI), with many individuals reporting cognitive symptoms during the chronic phase. Although blood-based biomarkers have been identified as a marker of injury severity in the acute ph...
Get full text
Article -
2
Early cerebrospinal fluid elevations of pTau-217 in severe traumatic brain injury subjects by Hamad Yadikar, Firas H. Kobeissy, Firas H. Kobeissy, Firas H. Kobeissy, Firas H. Kobeissy, Firas H. Kobeissy, Claudia Robertson, Spyridoula Tsetsou, John B. Williamson, John B. Williamson, Damon G. Lamb, Damon G. Lamb, Amy K. Wagner, Amy K. Wagner, Amy K. Wagner, Amy K. Wagner, Amy K. Wagner, Todd Kibaugh, Shih-Han Kao, Zhifeng Kou, Zhifeng Kou, Robert D. Welch, Jose-Miguel Yamal, Luis Leon-Novelo, Richard Rubenstein, Richard Rubenstein, Kevin K. W. Wang, Kevin K. W. Wang, Kevin K. W. Wang, Kevin K. W. Wang, Kevin K. W. Wang
Published 2025-07-01IntroductionTauopathies, including Alzheimer’s disease (AD), feature abnormal accumulations of hyperphosphorylated Tau protein; however, their biomarker potential in traumatic brain injury (TBI) is not well-defined. This study investigated whether cerebrospinal fluid (CSF) phosphorylated Tau at thre...
Get full text
Article